FEED NASDAQ
ENvue Medical, Inc.
1W: -23.6%
1M: -37.3%
3M: -67.1%
YTD: -61.4%
$0.93
+0.00 (+0.06%)
After Hours: $0.90 (-0.03, -3.29%)
Weekly Expected Move ±10.9%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider+$0.6M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.0M
52W Range0.8449-5.98
Volume1,181,600
Avg Volume3,003,696
Beta1.59
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODoron Robert Besser
Employees31
SectorHealthcare
IndustryMedical - Specialties
IPO Date2025-12-12
Websitenanovibronix.com
762 W. Algonquin Road
Arlington Heights, IL 60005
US
Arlington Heights, IL 60005
US
1 914 233 3004
About ENvue Medical, Inc.
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Latest News
Why 8x8 Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care
ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals
EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028
ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Glibert Christian Mi | J-Other | 0 | — | 2026-04-15 |
| BANK OF AMERICA CORP | S-Sale | 100 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 10 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 4 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 4 | $3.05 | 2026-02-02 |